EXDEN is a French CDMO Expert in Biotic Innovative Nutraceuticals, providing expertise in the development and manufacturing of probiotic-based dietary supplements. Established in 2007, EXDEN offers a range of services including sourcing probiotic strains, product formulation, stability studies, manufacturing, and packaging in an industrial environment compliant with HACCP/ISO 9001/GMP standards. The company also offers services such as organic certification, quality control, scientific documentation, regulatory compliance, and technical documents. With a focus on probiotics and prebiotics, EXDEN stays updated with the latest scientific advancements, particularly in intestinal microbiota, through its blog and monthly newsletter. Based in France, EXDEN operates within the manufacturing, nutrition, and pharmaceutical industries. As of now, there is no information available about the company's latest investment or investors. EXDEN stands as a prominent partner for companies seeking to develop and produce innovative nutraceutical solutions leveraging probiotics.
There is no investment information
No recent news or press coverage available for EXDEN.